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Abstract 
A phenomenological rate equation model is constructed to numerically simulate nanoparticle 
uptake and subsequent cellular response. Polyamidoamine dendrimers (generations 4-6) are 
modelled and the temporal evolution of the intracellular cascade of; increased levels of reactive 
oxygen species, intracellular antioxidant species, caspase activation, mitochondrial membrane 
potential decay, tumour necrosis factor and interleukin generation is simulated, based on 
experimental observations. 
The dose and generation dependence of several of these response factors are seen to well 
represent experimental observations at a range of time points. The model indicates that variations 
between responses of different cell-lines, including murine macrophages, human keratinocytes 
and colon cells, can be simulated and understood in terms of different intracellular antioxidant 
levels, and, within a given cell-line, varying responses of different cytotoxicity assays can be 
understood in terms of their sensitivities to different intracellular cascade events. 
The model serves as a tool to interpolate and visualise the range of dose and temporal 
dependences and elucidate the mechanisms underlying the in vitro cytotoxic response to 
nanoparticle exposure and describes the interaction in terms of independent nanoparticle 
properties and cellular parameters, based on reaction rates. Such an approach could be a valid 
alternative to that of effective concentrations for classification of nanotoxicity and may lay the 
foundation for future quantitative structure activity relationships and predictive nanotoxicity 
models. 
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Introduction 
Research involving nanoparticles has seen a huge increase in recent years. This is undoubtedly 
due to the novel properties these particles possess and their potential uses in a variety of fields 
including: medicine, electronics, engineering, cosmetics, food, textiles, packaging and many 
more.
1
  
Medical applications is a sector where nanomaterials have shown great potential and have 
already been used in several areas including: in vivo and in vitro diagnostic tools, biocompatible 
materials for implants, nutraceuticals, cancer therapy and, in particular, drug delivery.
2-8
 In terms 
of drug delivery, this interest is due to properties such as the ability to cross biological barriers 
easier than some more traditional delivery vehicles and the potential to escape from intracellular 
compartments such as lysosomes and endosomes.
9
 A full list of properties and potential uses for 
nanoparticles in drug delivery is somewhat outside the scope of this paper and has been reviewed 
elsewhere (De Jong et al., 2008).
10
 While the avenue of new medical applications does look 
promising, it has been found that some nanoparticles, when exposed to mammalian cells, elicit a 
toxic response.
11
 
In vitro studies indicate this toxicity to be the result of oxidative stress, manifest as increased 
Reactive Oxygen Species (ROS) production shortly after endocytosis,
12
 with subsequent 
trafficking of  the nanoparticle seen to occur through endosomes and lysosomes.
13,14
 The 
oxidative stress leads to a release of inflammatory factors
15,16,17,18,19,20,reviewed by 21
 and potential 
activation of apoptotic pathways.
22,23,24,25
 It is also important to consider processes such as 
endosomal rupture (endosomolysis),
9,14
 which can enhance the toxic response as released 
nanoparticles have been shown to localise in and subsequently damage organelles such as the 
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mitochondria.
15,16
 If medical applications are to remain a viable option for nanomaterials, then it 
will be essential to explore and better define the mechanisms involved in the toxic response. 
However, in the majority of current studies, in vitro toxicity is quantified using the effective 
concentration for 50% loss of viability (EC50) endpoint as an indicator of overall toxic effect. The 
EC50, is the result of a complex cascade of events which occur between the initial exposure and 
cell death; it gives no indication of the mechanisms, kinetics or efficacy of the interim processes. 
Additionally, the measured EC50 is dependent on the assay employed and the responses of 
different cell lines to the same exposure conditions have been shown to vary significantly.
16
 
Coupled with the broad range of nanoparticle compositions, structures, sizes and possible surface 
functionalisations, the result is a vast array of studies from which it is difficult to derive clear 
systematic trends.  
A more rationalised approach to nanotoxicity classification is becoming increasingly important 
because, as more and more nanoparticles are made available, testing via a case-by-case approach 
will not be sufficient.
26,27
 If nano-toxicology, and by extension nanomedicine, is to advance, the 
focus should be on: 
(i) Identification of the particle based properties which induce the cellular response,  
(ii) The cellular parameters which result in variations in that response, and   
(iii) The variability introduced by the use of different assays.  
By doing this, it may be easier to elucidate processes and events which are common to a large set 
of nanoparticles. Initial screening methods should be conducted in vitro, as there is a drive for a 
reduction in the use of animal models for evaluating toxicity, due to regulatory developments in 
both the EU and US (EU Directive-2010/63/EU and US Public Law 106-545, 2010, 106th 
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Congress)
28,29
 generally based on the 3 R’s of Russell and Burch30 to replace, reduce and refine 
the use of animals used for scientific purposes. Therefore, there is currently much promotion of 
the development of in vitro models which can accurately infer in vivo results. One strategy to 
help meet these requirements, recently endorsed by the OECD,
31
 is the analysis of Adverse 
Outcome Pathways (AOPs), by which a sequential chain of causally linked events at different 
levels of biological organization that lead to an adverse health or ecotoxicological effect is 
identified. The aim of the development of AOP is to i) guide the development of (in vitro) Test 
Guidelines, ii) provide a basis for the design of Integrated Approaches to Testing and Assessment 
(IATA), and iii) guide the development of molecular profilers for the QSAR toolbox. A QSAR
32
 
(Quantitative Structure Activity Relationship) can be used to identify and model traits which are 
common to entire sets of nanoparticles and hopefully elucidate how these properties/traits impact 
the overall toxicity. By advancing the knowledge of these models, it is hoped that, eventually, it 
will be viable to predict the full toxic profile of a cell which has taken up a nanoparticle.
33
  
In the field of nano-toxicology (in vitro), the endpoint is usually the median EC50 of a 
colorometric assay, but the choice of both assay and cell-line is large and little consideration has 
been given to the different modes of action of the assay within the cell. Many studies have 
explored the mechanisms underlying the toxic response, but little attention has been devoted to 
quantifiable comparison between different particles or cell lines, and relationship between 
endpoint and nanoparticle properties. The domain of nanoparticles is vast, but the paucity of 
systematic studies renders it difficult to establish domains of applicability of any structure-
activity paradigm, and therefore to define unambiguous algorithms or to validate based on 
statistical goodness-of-fit, robustness and predictability. 
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In the drive to develop a better understanding of the structural dependence of toxicity and 
mechanisms, studies using a homologous series of nanoparticles with systematically varied 
physico-chemical properties can play a vital role. Systematic variations of cellular uptake and 
mechanisms of response, such as oxidative stress and inflammatory responses can be compared 
to the systematic changes in the physico-chemical properties of the nanoparticle. A better 
quantitative understanding of the mechanisms of response allows a better insight into the 
function of the cytotoxicity assays, and how the endpoints vary systematically with nanoparticle 
properties, but also with cell line, ultimately laying the foundation for the development of 
quantitatively predictive models for cellular response.
27
 
Polyamidoamine (PAMAM) dendrimer nanoparticles are a homologous series of nanoparticles of 
well defined physico-chemical properties which are systematically variable and elicit 
systematically variable cellular responses. PAMAM dendrimers are branched in conformation 
and consist of three main parts, (i) the initiator core, (ii) the interior branches and (iii) the 
exposed branch termini.
34
 Each set of these branches is called a Generation (G) and the 
generation determines the number of surface amino groups according to the formula: 
G
)0G(BPamg 2.NN         Equation (1) 
where Namg is the number of surface amino groups, NBP(G0) is the number of initial branching 
points at generation zero (G0) and G denotes the generation number. Thus, the diameter and 
number of surface amino-groups increases systematically with increasing generation. 
This well defined branched system allows for the variation of parameters such as: Terminal 
modification via addition of cationic, anionic or neutral molecules, zeta potential and in 
particular generation, which will govern: number of amino groups and therefore effective surface 
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charge, diameter and overall particle size. Ultimately this system lets us examine how these 
characteristics impact the cell-nanoparticle interaction and therefore may shed light on the 
processes involved in toxicity. Previous studies of exposure of aquatic species
35
 and in vitro 
mammalian cell cultures
16,23
 have demonstrated that the polymeric dendrimer series with 
systematically varied structures elicits toxic responses which are well correlated with the 
variations in physico-chemical properties.  
Uptake of these PAMAM dendrimers occurs via endocytosis, where the nanoparticle is 
enveloped in cellular membrane and transported into the cell.
23,36,37
 The toxic response has been 
shown to derive from an increased production of intracellular Reactive Oxygen Species (ROS) 
after endocytosis.
17
 The ROS production is counteracted by cellular anti-oxidants, one example 
of these being Glutathione (GSH), a thiol based tri-peptide.
38
 After this, a cascade of different 
events and the release of several characteristic cytokines and chemokines occurs. Studies have 
shown that, for PAMAM dendrimers in HaCaT cells, an immortalized human keratinocyte line, 
activation of caspases 8 and 3 occurs at around 1-2 hrs, followed by mitochondrial membrane 
potential decay (MMPD) (3-4hrs), after which there is a release of TNF-α (4-5hrs) and eventually 
IL-8 which then maximises at 24 hours.
38 
It has also been proposed that larger generation 
dendrimer nanoparticles and/or doses can cause the endosome to rupture (endosomolysis), via the 
so-called proton pump mechanism.
39,40,41
 Supported by the fact that after ~16hrs the PAMAM 
dendrimers have been seen to be located in the mitochondria,
22,38
 whereupon the oxidative stress 
is further increased, resulting in further MMPD, which can culminate in apoptosis. A similar 
inflammatory cascade has been reported in murine macrophages, although the evolution of the 
responses was observed to be somewhat slower.
17 
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In both cases, the temporal profile was seen to be systematically dependent on dendrimer 
generation and dose, pointing towards the basis of potential structure property relationships. 
However, more than a single measurement at a single time point by a cytotoxic assay, the 
measurement of the time evolution of the cascade provides a clearer picture of the set of events 
and the visualisation of different timescales allows for a better evaluation of differences due to 
nanoparticle properties and cell lines.  
It is proposed that, by measuring and numerically modelling the kinetics of the cellular responses 
and their dependence on nanoparticle properties, a more intuitive formulism of the nanotoxic 
response which more clearly tracks the cellular response related to nanoparticle properties can be 
established. The approach lends itself naturally to an AOP formalism, but the systems biology 
like approach adds quantification of the rates of response, which are related to the physico-
chemical properties of the nanoparticles, such that the approach may ultimately lead to QSARs 
and predictive models of cytotoxic response. These predictive models would be able to provide 
some preliminary data on toxicity which could be used to inform initial testing strategies.  
The model presented in this study looks at PAMAM toxicity based on previously published 
experimental data.
16,17,23,35,38
 A preliminary form of the model faithfully reproduced the time 
course of the toxic responses of the HaCaT cell-line to PAMAM dendrimer exposure, including 
the experimentally observed generation dependence.
38
 This study critically extends the model to 
the dose dependent responses of cell lines to nanoparticle exposure, and elucidates the origin of 
the dependence of EC50 on cell-type and cytotoxic assay dependent results. The approach argues 
for a classification of toxic responses based on activity of the particles, expressed as particle and 
cell dependent reaction rates, rather than Effective Concentration end points. 
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Materials and Methods 
Experimental results are derived and adapted from previous work by the authors
16,17,23,35,38
 and 
details of the materials and methods used can be viewed in these publications. However, below is 
a brief summary of the experimental methods employed. 
Naha et al. detail the dose and generation dependence of the toxic responses of murine 
macrophages, the J774A.1 cell line, to exposure to PAMAM generations G4, G5 and G6. The 
J774A.1 cells were cultured in Dublecco’s Modified Eagle’s Medium (DMEM), supplemented 
with 10% FBS, 2mM L-Glutamine and 45IU/mL streptomycin and penicillin at 37˚C in 5% CO2. 
The following exposure dose ranges were used: 0.08µM to 6µM for G4, 0.03µM to 2µM for G5 
and 0.013µM to 1µM for G6. For all generations, the dose dependence of ROS production was 
monitored by the fluorimetric assay, Carboxy-H2DCFDA and was performed in black 96 well 
plates with a cell concentration of 4x10
5
cells/mL. DMEM was used as a negative control and 
H2O2 was used as positive control. Readings were taken at 1hr, 2hrs, 4hrs and 6hrs, with λex 
(excitation wavelength) = 485nm and λem (emission wavelength) = 520nm. The temporal 
evolution of the inflammatory cascade of TNF-α and Interleucin 6 (IL-6) was monitored at a 
fixed dose of 1μM using the ELISA assay, where LPS was used as a positive control to verify the 
procedure and the absorbance was read at 405nm. Cytotoxicity was measured using the MTT 
assay, with 0.5mg/mL dye concentration and readings were take for time points: 6hrs, 12hrs, 
24hrs, 48hrs and 72hrs, at an absorbance of 595nm.
17,38 
Mukherjee et al. detail the dose and generation dependences of the toxic responses of the 
immortalised human keratinocyte (HaCaT) and primary adenocarcinoma colon (SW480) cell 
lines. The cell lines were cultured in the same conditions as described above using DMEM F12 
HAM and with an additional 1μg/mL hydrocortisone added for the HaCaT cells. The following 
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exposure dose ranges were used: 0.01µM to 21.1µM for G4, 0.03µM to 5.2µM for G5 and 
0.01µM to 5.168µM for G6. Dose and generation dependent cytotoxicity for both cell lies was 
measured using the MTT, Alamar Blue and Neutral Red assays at 24hrs. The MTT assay was 
performed with 5mg/mL dye concentration and read at an absorbance of 595nm. Alamar Blue 
and Neutral Red were performed in the same 96 well plates which were seeded at a concentration 
of 1x10
5
 cells/mL. Alamar Blue was performed with a concentration of 5% [v/v] and results were 
measured using a fluorimeter with the λex = 485nm and λem = 520nm. Neutral Red was performed 
with a dye concentration of 1.25% [v/v] and results were measured using a fluorimeter with the 
λex = 531nm and λem = 642nm. The temporal evolutions of ROS, apoptosis and DNA damage 
were monitored for the HaCaT cell line. ROS was again measured with the Carboxy-H2DCFDA 
and was performed with a cell concentration of 1x10
5
cells/mL. Readings were taken between 1-
4hrs and at 24hrs for HaCaT cells, and between 30mins-6hrs and at 24hrs for SW480 cells with 
λex = 490nm and λem = 545nm. Apoptosis was measured with flow cytometry, using the YO-
PRO-1/Propidium dyes at a concentration 1μL per 1x106cells/mL. The TUNEL assay was used to 
detect DNA damage at a time point of 24hrs.
16,23
 
 
Numerical results for all equations were obtained by integration using the iterative Euler 
approach
42
 and SigmaPlot™ (v.10.0) was used to generate the values and graphs.
 11 
Results 
Generation of the Equations 
In order to better visualise the full range of dose and temporal dependencies and elucidate the 
mechanisms of response, the system was modelled using a relatively simple phenomenological 
rate-equation model. This model is similar, in concept, to ones commonly employed for 
modelling molecular-photodynamics.
43
  
 
 
Scheme 1. Schematic of systematic sequence of events upon nanoparticle uptake. 
A schematic representation of the sequence of events upon nanoparticle uptake, where the cell 
(system) takes up a particle, progresses to ROS damage (quenched by anti-oxidants), then onto 
mitochondrial damage, inflammatory cascade and finally apoptosis (if the cellular recovery rates 
are insufficient). 
 
Scheme 1 illustrates the systematic sequence of events which can occur when a nanoparticle is 
taken into a mammalian cell. 1: Upon exposure, the cells take up nanoparticles at a rate kendo, 
leading to two populations: cells without nanoparticles (i.e. in a ground/non-toxic state), Nground, 
and cells with an endocytosed nanoparticle Nendo. Also indicated is a possible “exocytosis” 
process, occurring at a rate kexo. However, Salvati et al. have indicated that this does not occur for 
N(ground) 
Nendo 
NROS 
N(ground) N(ground) N(ground) 
Nmito 
N(Inflam) NApop 
kendo kexo 
kq 
kROS 
kmito 
krec 
k(Inflam) 
krec 
kApop 
EXPOSURE 
1 
2 
3 
4 
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polymeric nanoparticles and therefore it is not included in the equations.
14
 2: The next step in the 
sequence is ROS generation at a rate kROS, again generating a new population NROS. The ROS can 
then be quenched by the action of antioxidants, at a rate denoted here by kq. 3: Alternatively, the 
system progresses to mitochondrial damage at a rate kmito. 4: This process continues through a 
cascade and can culminate in apoptosis if the cellular recovery rates (krec) are not sufficient.  
The complex system illustrated schematically in Scheme 1 can be better described using a series 
of rate equations. The process of nanoparticle endocytosis by cells in vitro, taking into account 
the cell replication rate (kλ), has previously been described by Salvati et al.
14
 and is here 
described by Equation 2. As the dose (D) is expressed as the molar dose, for ease of comparison 
with the experimental data, Nendo is an expression of the molar quantity (number per unit volume) 
of endocytosed dendrimer nanoparticles. In subsequent equations, the term “N” is used to denote 
the equivalent quantity denoted by the subscript text that follows.  
(t).Nk.D).(Nk
dt
dN
endoλ
c
amgendo
endo 
    Equation (2) 
where kendo is the rate of endocytosis (in units of inverse time), Namg is the number of amino 
groups per particle, c is an empirically determined fit factor, kλ accounts for cellular replication 
and D is the molar dose. Assuming a cell duplication half life of 24hrs, kλ has a value of 
(0.69/24)hr
-1
. 
After endocytosis, nanoparticles generate ROS and this build-up of ROS is counteracted by the 
intrinsic intracellular anti-oxidants, in this study exemplified by GSH, and the interaction 
quenches both the levels of ROS and GSH. These processes have previously been described by 
Equations 3 and 4.
38 
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)t(N).t(N.k)t(N.G.k
dt
dN
GSHROSqendoROS
ROS 
   Equation (3) 
qGSHROSGSH
GSH k).t(N).t(Nk
dt
dN

     Equation (4) 
The first term in Equation 3 is a generation (G) and dose (D) dependent term describing 
continuous ROS generation at a rate kROS (NROS(0) = 0). The second term describes the quenching 
of the ROS at a rate kq, and depends on both; ROS levels, NROS, and antioxidant levels, NGSH 
(NGSH(0) = 0). In the study by Mukerjee et al., the antioxidant levels were represented by the 
experimentally measured values of Glutathione (GSH).
38
 In Equation 4, the experimentally 
observed linear increase of the control levels of GSH, at a rate of kGSH, is described by the first-
term, and the second-term, which is the same as in Equation 3, describes the quenching of the 
GSH levels. Values of kGSH and kq are derived from the experimental data and simulations of 
Mukherjee et al.
38
 
The subsequent, experimentally observed, cascade of cellular responses can be similarly 
simulated. The cascade elements examined were: caspase activation, mitochondrial membrane 
potential decay (MMPD), tumour necrosis factor alpha (TNF-α) and interleukin-8 (IL-8) for 
HaCaT cells, or interleukin-6 (IL-6) for mouse macrophages. In the model of Mukherjee et al.,
38 
the early stage caspase activation and MMPD are both a result of increased levels of ROS, 
although through independent pathways. Thus:  
)t(N.k)t(N.k
dt
dN
Casp2CaspROSCasp
Casp

    Equation (5) 
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(t).Nk    (t).Nk 
dt
dN
MMPTNFROSMMP
MMP 
    Equation (6) 
(t).Nk    (t).Nk 
dt
dN
TNF8-ILMMPTNF
TNF 
    Equation (7) 
(t).Nk 
dt
dN
TNF8-IL
8-IL 
       Equation (8) 
Again, in Equations 5 to 8; N describes the respective populations at time (t) and k the respective 
rates and the initial conditions for all cases are such that N(0) = 0. Overall, these equations show 
a possible cascade of events involving; ROS production, parallel rather than sequential processes 
of caspase activation, loss of MMP, the latter leading to activation of TNF-α and IL-8, as 
described for HaCaT cells exposed to PAMAM dendrimers by Mukherjee et al.
38 
 
Cell viability was monitored using the MTT assay.
16,17
 MTT measures the mitochondrial activity 
and is thus experimentally most associated with changes in the mitochondrial membrane 
potential, loss of which can, at certain levels, lead to apoptosis. The following equation was used 
to calculate the change in the population of viable cells, NV: 
 (t)(t).N.Nk   (t).N(t).Nk 
dt
dN
VMMPVV
b
MMPRec
V 
  Equation (9) 
The second term of Equation 9 describes the process of cell death, dependent on the change in 
the mitochondrial membrane potential, and the number of viable cells. As not all cells would 
undergo apoptosis as a result of loss of MMP, the first term of Equation 9 allows for a process of 
cell recovery, at a rate kRec, and an empirically determined sub-linear dependence (b) on NMMP 
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makes this process more prominent at lower doses. NV is initially set equal to a value of 1 to 
represent 100% cellular viability. 
The phenomenological rate equation model thus enables simulation of the time evolution of the 
cellular responses as well as the measured cytotoxic response.  
Notably, the only particle dependent parameters are the nanoparticle dose (D) and generation (G). 
It is demonstrated that the model can reproduce the experimentally observed variations of 
cytotoxic response as a function of dose and generation, as well as measurement time-point and 
the dependence on cell-line parameters such as intrinsic intracellular antioxidant levels.  
Temporal Evolution 
For a fixed dose and generation, the temporal evolution of the cellular responses has previously 
been faithfully simulated using the rate equation model with the HaCaT cell-line.
38
 The model 
can be extended to the J774A.1 cell-line, for G4 exposure at a fixed dose of 1M, as shown in 
Figure 1 (experimental data reproduced from Naha, P.C. et al, 2010
17
). Experimental data (as 
symbols) is shown only for ROS and TNF-α as well as the temporal dependence of the MTT 
viability assay (as symbols and dotted line as a guide to the eye). The solid red line indicates the 
simulated ROS production and the other dotted lines show the temporal evolution of: Caspases 
(Green), MMPD (Orange) and TNF-α (Purple) as simulated according to Equations 3 to 8. For 
both experimental and simulated data, results are normalised to a maximum value of 1 for 
visualisation purposes, with the exception of the MTT data (viability – blue dotted line), which 
experimentally have been normalized to the unexposed control
17
. Parameters employed for the 
simulated data of Figure 1, and for all subsequent figures, are listed in Supplemental Information, 
Table S1. The sensitivities of the temporal, dose and generation dependences of the simulated 
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data to variations of these parameters are analysed in the Discussions and Conclusions section, 
and, where appropriate, in the Supplemental Information. 
 
Figure 1. Experimental (from Naha, P.C. et al, 2010
17
) and simulated cellular responses of 
J744A.1 murine macrophages to exposure to G4 PAMAM dendrimers at a fixed dose of 1M. 
Results are normalised to a maximum value of 1 for visualisation purposes, with the exception of 
the MTT data (viability), which experimentally have been normalized to the unexposed control. 
 
ROS Dose Dependence 
The rate equation model can therefore be applied to simulate the temporal evolution of the 
cellular responses to exposure to PAMAM dendrimers at a fixed dose. Furthermore, in the 
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previous study by Mukherjee et al., the generation dependences of Equations 2 and 3 were seen 
to faithfully reproduce the experimentally observed more rapid onset of ROS production with 
increasing dendrimer generation.
38
 Notably, however, using a constant ROS generation rate, kROS, 
the ROS levels were found to increase monotonically as a function of time, and it was found 
necessary to constrain the rate of generation to decrease, dependent on the amount of ROS 
generated, indicative of a depletion of the source of ROS. In the preliminary model of Mukherjee 
et al,
38
 this was achieved through the relationship of Equation 10. 
)t(N.k
dt
dk
ROSROS
ROS 
      Equation (10) 
While this approach allowed the faithful reproduction of the temporal evolution of the ROS 
levels, it does not accurately model the complex dose/generation dependence of the ROS levels 
at a fixed time point, as shown in Supplementary Information Figure S1. Figure 2 shows the dose 
and generation dependent levels of ROS in the J774A.1 cell-line, expressed as the percentage 
increase in Carboxy-H2DCFDA fluorescence compared to control, at a fixed timepoint of 4hrs 
(data derived from Naha, P.C. et al, 2010
17
). 
The dose dependence of Figure 2 can however be reproduced by considering that the increased 
levels of ROS are the result of an interaction of the endocytosed nanoparticles with an 
intracellular source of ROS, Nsource, which is depleted by the ROS generation process. Thus, 
)(t)).(N(t).(N*.Gk 
dt
dN B
Source
A
endoA
Source 
   Equation (11) 
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where kA is the interaction rate for the nanoparticles and source, G* is a generation dependant 
factor and the values for A and B are empirical constants. The generation of ROS, previously 
described by Equation 3, is then described by: 
(t)(t).N.Nk    )(t)).(N(t).(N*.Gk 
dt
dN
GSHROSq
B
Source
A
endoA
ROS 
 Equation (12) 
The continuous lines of Figure 2 show the simulation of the dose and generation dependent 
increase in ROS in the J774A.1 cell-line, as calculated at 4hrs, in comparison to the 
experimentally observed values. The simulated data are expressed in arbitrary units, and have 
been scaled to give a best match to the experimental data. Experimentally, a background level of 
~ 10% was observed at even the lowest doses and thus the simulated data, which begins at a 
value of zero, are offset for comparison.  
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Figure 2. Experimentally observed (symbols) (expressed as the % increase in Carboxy-
H2DCFDA fluorescence compared to control, at a fixed timepoint of 4hrs
17
) and simulated 
(lines) dose and generation dependent intracellular ROS generation after 4hr exposure of 
J744A.1 mouse macrophages to PAMAM dendrimers. 
The simulated data of Figure 2 are generated from Equations 1-14, simultaneously for all three 
dendrimer generations, with only G and D as variables. The closest simulated reproduction of the 
experimental data was achieved using a generation dependent expression of G* and A, with a 
constant value of B = 3, such that: 









25.0
amgN
1
*G
 
75.0
amg
64
N
A 








 
Note, in the simulated data of Figure 2, a value of 0.25 was used for “c” of Equation 2. The 
initial value of Nsource(t=0) was chosen to be 10M, the maximum dose level used in the 
simulation. 
The simulation faithfully reproduces the dose and generation (number of surface amino groups) 
dependence of the production of ROS. Notably, for each generation, the maximum levels of ROS 
production saturate at the same value, consistent with experimental observations supporting the 
proposition that the surface amino groups are the primary source of the response to the 
nanoparticle intake.
24
 The evolution of the equations (from Equation 10 to Equations 11 and 12) 
to account for the dose dependence of the ROS response has little effect on the temporal profiles 
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of the cellular responses at a fixed dose, and the responses represented in figure 1 are calculated 
using the latter formalism rather than that of Equations 3 and 4.  
Experimentally, the evaluation of the dose (7 dose measurements) and generation (3 generations) 
dependent increases in ROS levels as well as their temporal evolution (1-24hrs) is an extensive 
series of measurements, in independent triplicates. Having established a model which can 
faithfully simulate the responses of the cell line, a 3-D representation of the combined and 
continuous dose dependence and temporal evolution can be constructed, as shown in figure 3 for 
the case of G4. Similar 3-D representations can be constructed for G5 and G6, and the model can 
be readily extrapolated to higher and lower generations. Although the 2-D representation of the 
3-D system does not do it justice, the view illustrates the importance of considering the3-D plane 
in the system response. 
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Figure 3. A 3D graph showing both the simulated time and dose dependence of the ROS 
evolution, in J744A.1 mouse macrophages, upon G4 PAMAM nanoparticle uptake. 
 
Cellular Viability 
It is clear that the approach of the phenomenological rate equation model can accurately 
reproduce the experimentally observed cellular responses, as a function of dose and generation, 
as well as their temporal evolution. For the given cell-line, the responses are determined by the 
surface reactivity of the nanoparticles, which, in the case of PAMAM dendrimers presented here, 
depends on the number of surface amino groups per particle for each generation. Ultimately, the 
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response to nanoparticle exposure is reduced viability in the in vitro culture, as measured by 
cytotoxicological assays such as MTT, and normally represented by the EC50. It has previously 
been shown that the cytotoxicity of PAMAM dendrimers is systematically dependent on 
generation, but, given the complex dose and temporal responses, the exact link to nanoparticle 
structure and reaction mechanisms has not been elucidated. 
Figure 1 also plots the experimentally observed MTT EC50 value at different time points (from 
Naha, P.C. et al, 2010
17
). For a given generation, the dose dependence of the reduction in 
cellular viability at different timepoints can be simulated according to Equation 9. Figure 4 
illustrates the simulated dose dependence of the cellular viability, for a single generation (G4), at 
6hrs, 12hrs and 24hrs, compared to the corresponding experimentally observed MTT response at 
these timepoints (from Naha, P.C. et al, 2010
17
). All parameters used to simulate the dose 
dependence of the ROS (figure 2) as well as the temporal evolution of the cellular responses 
(figure 1) are kept constant and only the dose is varied. A value of 0.25 was employed for the 
parameter b in Equation 9. The model, with reasonable accuracy, reproduces the in vitro cellular 
responses observed experimentally. The simulated results are best matched to the experimental 
responses at the earlier (6hr) and later (24hr) timepoints. The deviation from the observed 
responses at the intermediate timepoint (12hrs) may be the result, for example, of more complex 
quenching mechanisms not included in the model at this stage.   
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Figure 4. Experimental (symbols) and simulated (lines) dose dependent viability, as measured 
using the MTT assay, for J744A.1 murine macrophages at 6hr, 12hr and 24hr (experimental data 
from Naha, P.C. et al, 2010
17
). 
By varying the generation (G), for a fixed time point, the dose dependence of the cellular 
viability for each generation can be similarly qualitatively reproduced, as shown in figure 5, for 
the case of 12hr exposure of mouse macrophages (experimental data derived from Naha, P.C. et 
al, 2010
17
). 
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Figure 5. Experimental (symbols) and simulated (lines) dose dependent J744A.1 mouse 
macrophage viability at 12 hrs, as measured using the MTT assay, for PAMAM generations G4, 
G5 and G6 (experimental data from Naha, P.C. et al, 2010
17
). 
Similar to the case of the ROS, a 3-D representation of the simulated cytotoxic response of 
HaCaT cells to PAMAM dendrimer exposure, as a function of dose and time, can be constructed, 
as shown in Figure 6 for the case of G4. A similar representation can be made for G5 and G6, 
and the model is readily extendable to higher or lower PAMAM generations.  
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Figure 6. 3D simulated time and dose dependence of MTT response for exposure of J744A.1 
murine macrophage cells to PAMAM G4. 
The experimental data of Figure 5 is a typical representation of a cytotoxicological screening of 
nanoparticles. In comparing the responses of the cell line to the different generations in the 
dendrimer series, a systematic structural dependence of the response is clear. The application of 
the model presented here demonstrates that that dependence is derived from the number of 
surface amino groups per dendrimer generation, and the rate of generation of ROS. The true 
value of any such model, however, depends on its applicability to a range of different 
experimental scenarios.
32
 One notable source of diversity in the literature on in vitro 
nanotoxicology is the range of different cell lines used, often justified as models for target organs 
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in vivo. Indeed, in the work of Naha et al., and Mukherjee et al., a range of different cell lines 
were employed.
16,17,23,24,38
 In addition to the murine macrophages already described in this 
manuscript
17
, the human colon adenocarcinoma cell line (SW480) and the immortalised human 
keratinocyte line (HaCaT) were employed as models of ingestion and transdermal transport of 
nanoparticles respectively.
16,23,38
 Notably, the different cell lines gave significantly different 
results for the cytotoxicity of PAMAM dendrimers, as shown in figure 7 for the examples of the 
dose dependent viability as measured using the MTT assay upon exposure of the different cell 
lines to PAMAM G4 for 24hrs. Although an extrapolated EC50 from the J774A.1
17
 and SW480
16
 
cell lines would yield similar results, the value for HaCaT
16
 is considerably higher, indicating a 
greater resistance of the skin cell line to external insult, as may be expected.  
Variability: Cell lines and Assays 
Following the cascade of cellular responses after nanoparticle endocytosis, described in Figure 1 
and represented by Equations 2-14, a potential source of the differences in cell type responses to 
nanoparticle exposure is the constituent levels of cellular antioxidants, redox enzymes etc., which 
help the cell to protect itself from the oxidative stress caused by an external agent. For example, 
the average activities of three important intracellular redox agents, glutathione (GSH), 
glutathione-S-transferase, and glutathione reductase are approximately three times higher in 
WI38 human fibroblast cells than in HaCaT cells and therefore, upon 24 h exposure to arsenic, 
HaCaT cells have been reported to be 50% more susceptible to cell death than WI38 cells.
44
 Of 
relevance to the study presented in figure 6, the natural intracellular glutathione (GSH) level of 
HaCaT cells are reported to be 7300 nmol/mg protein
44
 whereas those of SW480 and J774A.1 
cells have been reported to be ~40 nmol/mg protein
45
 and 26.7 nmol/mg protein,
46
 respectively. 
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The higher level of antioxidants in HaCaT cells is therefore consistent with a greater resistance to 
external insult. In the rate equation approach presented here, this internal resistance to oxidative 
stress is represented by kGSH in Equation 6. The solid/dashed lines of figure 7 represent the 
simulated viability for the different cell lines, calculated according to Equation 12, having 
increased only the rate of generation of GSH for the HaCaT cell line (by a factor of 1.5), in 
Equation 4, keeping all other rates constant. It can be seen that the simple change in the cell 
dependent response parameter faithfully reproduces the experimentally observed differences in 
response for the different cell lines. The increased levels of GSH result in a more rapid 
quenching of the intracellular ROS levels, and this is manifest experimentally as an initial 
maximum in HaCaT cells after 1-2 hrs,
38
 whereas in J774A.1 cells, the maximum is observed at 
3-4 hrs (Figure 1).
17
 
 
 28 
Figure 7. Experimental (symbols) and simulated (lines) viability of different cell lines, as 
measured using the MTT assay, after exposure to PAMAM G4 for 24hrs. Experimental data for 
J774A.1 derived from Naha, P.C. et al, 2010
17
. Experimental data for SW480 and HaCaT 
derived from Mukherjee, S.P. et al.  2010
16
. 
 
Figure 8. Comparison of Experimental (symbols) and simulated (lines) viabilities as measured by 
MTT, Alamar Blue and Neutral Red, for exposure of SW480 cells to PAMAM G4 after 24 hrs. 
Experimental data from Mukherjee, S.P. et al.  2010
16
. For each assay, the data has been 
normalized to unexposed control. 
Literature furthermore describes the use of a diverse range of endpoints to evaluate the cytotoxic 
responses of cell lines in vitro. Each assay measures a different underlying cellular response or 
function. As discussed above, MTT measures the mitochondrial function. Alamar Blue is a 
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fluorescence based assay which is used to assess cell viability and proliferation; this is done by 
measuring the innate metabolic activity via the conversion of resazurin (non-fluorescent) to 
resorufin (fluorescent).
47
 Neutral Red is another fluorometric dye, which measures the lysosomal 
activity using 3-Trimethyl-2,8-phenazinediamine, monohydrochloride, which binds to the 
lysosomes of viable cells.
48
 Mukherjee et al. have highlighted how the different sensitivities of 
the assays as a result of the exposure to PAMAM dendrimers are a manifestation of the 
mechanism of interaction of the nanoparticles with the cells.
38
 Figure 8 reproduces the 
experimental values of the dose dependent viability of SW480 cells after 24hr exposure to 
PAMAM G4 as measured by the MTT, Alamar Blue and Neutral Red assays (from Mukherjee, 
S.P. et al.  2010
16
). For each assay, the data has been normalized to unexposed control. 
In the rate equation model presented here, the responses of the assays are represented by different 
steps in the cascade of cellular responses following exposure. The MTT response is associated 
with changes in mitochondrial membrane potential, and is simulated by Equation 9. The lower 
sensitivities of the Alamar Blue and Neutral Red assays indicate that they are associated with 
later responses in the cascade. The Alamar Blue response can be associated with the subsequent 
phase of generation of TNF-α and modelled according to Equation 13.  
)t('.N)t('.Nk(t)'.N)t('.Nk
dt
'dN
V
m
αTNFVV
b
αTNFrec
V
 
 Equation (13) 
Note that NV’ in Equation 13 represents the number of viable cells as registered by Alamar Blue. 
NV’(0) = 1 represents the initial 100% viability. In modelling the experimental data of Figure 8, 
for Alamar Blue, it is noted that an empirical factor of m=2 provides a good fit and a value of b 
= 0.25 was again used.  
 30 
In a similar fashion, the response of Neutral Red can be associated with a later stage of the 
cascade of cellular responses and simulated according to Equation 14: 
(t)''.N)t('.N'k(t)''.N)t('.N'k
dt
''dN
V
p
8ILVV
b
8ILrec
V
 
 Equation (14) 
NV’’(0) = 1 represents the initial 100% viability. A good reproduction of the experimental results 
is found with an empirical factor of p=3 and b = 0.25. In Equations (13) and (14), krec’ and krec’’, 
and kV’ and kV’’ describe the rates of recovery of the system without apoptosis, and the rates of 
change of the viability, as measured by the respective assay. 
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Discussion 
The phenomenological rate equation model presented here is a demonstration of how an 
integrated approach to analysis of the responses of cells to nanoparticle exposure can be 
employed to provide a better visualisation of the dependences of those responses on experimental 
parameters such as dose and exposure time, nanoparticle characteristics (such as number of 
active surface groups) and even variations in cell line and cytotoxicity assay. The model is 
constructed on previous experimental observations of the cellular responses to PAMAM 
dendrimers, which have systematically variable physico-chemical properties, and have been seen 
to elicit systematically varied cellular responses. The mechanisms of response and their causal 
nature and inter-relationships have been explored and discussed extensively elsewhere.
16,17,23,38
 
While it is impractical at this stage to cover all such potential cellular responses, the model is 
used to simulate several known cytotoxic markers, simultaneously for all 3 dendrimer 
generations, and thus is at least a partial system of events. Such a system of events can be 
considered as a sub-section of an Adverse Outcome Pathway
49,31 
and is consistent with the 
approach of predictive paradigms for assessing nanotoxicological responses.
50,33
 
The initial stage of endocytosis has previously been described using a rate equation approach for 
the uptake of 40-50 nm fluorescently labelled polystyrene nanoparticles in the A549 human lung 
adenocarcinoma cell line, as measured by flow cytometry.
14 
Endocytosis rates were measured and 
simulated according to build up of cellular fluorescence, and the values of kendo in the current 
model were chosen to yield similar simulated results for the build up of dendrimer nanoparticles 
in the cells, as shown in supplementary material Figure S2. In contrast to the fluorescently 
labelled PS nanoparticles, the dendrimers are not easily visualized within the cells and so the 
cellular response of increased levels of ROS was used to guide the simulation of the time, dose 
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and generation dependence of the cellular responses. Figure S4 shows the sensitivity of the 
simulated dose dependent ROS generation to variations in the parameter kendo. In the current 
model, the best simulations were achieved by including a generation (Namg) dependent factor in 
the uptake, as described in Equation 2, with a c value of 0.25. For comparison, Supplementary 
Figure S4 compares the dose dependent generation of ROS after 4hrs exposure for all 3 
generations, with varying values of the parameter c. The best replication of the response for all 
generations simultaneously is achieved using a value of c=0.25. In understanding the potential 
significance of this factor, it is worth observing that the relationship between the diameter and 
the number of surface amino groups for PAMAM dendrimers in the region of Namg = 20-1000 is 
a power law of order 0.25 (data from http://www.dendritech.com/pamam.html). The nominal 
diameters of PAMAM dendrimers available on the dendritech website are in good agreement 
with those measured by size exclusion chromatography.
51
 The values of hydro-dynamic diameter 
measured by Dynamic Light Scattering in PBS are somewhat larger, as may be expected, but the 
values still scale systematically with generation and although a slight increase in cell culture 
medium due to interaction with the medium may be inferred, no significant 
aggregation/agglomeration of the particles is evident over the dose ranges measured.
16
 Thus, a 
dependence of the rate of endocytosis on Namg
0.25
 may represent a dependence on the dendrimer 
diameter, which varies only slightly with generation number (G4 diameter: 4.5nm, G5 diameter: 
5.4nm and G6 diameter: 6.7nm 
16
). 
The model considers the case of PAMAM dendrimers which have been demonstrated to be taken 
up in mammalian cell lines by a process of endocytosis.
14
 However, endocytosis can be 
subcategorised into four different types: Clathrin-mediated endocytosis, Macropinocytosis, 
Caveolae-mediated endocytosis and Phagocytosis, all of which could be readily modelled via 
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modification of the rate equation approach used in this study. It is also important to note that, for 
smaller generation dendrimers, a potential for passive uptake is also possible. It would be of great 
interest to continue to reduce the dendrimer size and explore the transition between the 
dominance of active and passive uptake mechanisms, which could be incorporated as a parallel 
uptake process using such a rate equation approach. 
While a more primitive version of the model presented here was capable of reproducing the 
temporal evolution of the cellular responses, and to some extent the dependence on dendrimer 
generation,
38
 an accurate model of the complex dose dependence of the increase in intracellular 
ROS is key to extending the model to simulate the dose dependent cytotoxic responses. 
The intracellular levels of ROS increase upon nanoparticle endocytosis but are seen to reach a 
maximum on a time scale of 1-4 hours, depending on the dendrimer generation, dose and cell 
line.
17,38
 In the rate equation formulation presented here, this transient behaviour cannot be 
reproduced simply by introduction of an anti-oxidant quenching mechanism. Rather, a limit to 
the capacity of the cell to generate increased levels of ROS is inferred. This process is 
represented by the reaction of the endocytosed nanoparticles with a source species, which 
generates ROS, while consuming the source. The approach enables faithful simulation of both 
the temporal evolution and the dose and generation dependence of the ROS.  
The approach is analogous to that of the Operational Model of Agonist Activation,
52 
which 
invoked the concept of an agonist receptor, to which the agonist binds, to produce the response. 
Using the law of Mass Action at equilibrium, a faithful reproduction of a sigmoidal response 
curve to a linear agonist dose was achieved, based on the agonist concentration, the receptor 
concentration and the agonist/receptor dissociation rate.  
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In considering the biological significance of an ROS source, Nsource, understanding the 
mechanisms of ROS generation is important and has been discussed in the supplementary 
information (ROS source discussion).  
Although the exact process of ROS production has not been experimentally visualised, the model 
can still faithfully reproduce the dose and generation dependence of the increase in ROS levels, 
using Equations 11 and 12, as shown in Figure 2.  All curves of Figure 2 can be modelled with a 
constant value of kA. Figure S5 of the supplementary information illustrates how the simulated 
dose dependent increase in the ROS levels for all three generations at a fixed timepoint of 4hrs 
depends on variation of the parameter kA. This value is normalised by the factor G* = Namg
-0.25
. 
The sensitivity of the simulations to the exponent of this parameter is shown in Figure S6. 
Notably, this is the inverse of the factor employed for Equation 2, and, in the light of the 
discussion above, can be related to the generation dependence of the dendrimer diameter.  
For a given dendrimer generation, the rate of generation of ROS is dependent on 
Nendo(t)
A
.NSource(t)
B
. As the dose (D) is expressed as the molar dose, for ease of comparison with 
the experimental data, Nendo is an expression of the molar quantity of endocytosed dendrimer 
nanoparticles. Figures S7 and S8 demonstrate the sensitivity of the simulated dose dependent 
ROS generation on the parameters A and B respectively. The dependence of the power law factor, 
A, on the number of amino groups, Namg, is a reflection of the increasing reactivity per dendrimer 
nanoparticle with generation. The value of B=3 indicates that, in the reaction process, 3 source 
species are involved. 
In understanding the influence of the different parameters of Equation 12 on the form of the dose 
dependent ROS generation of Figure 2, and by analogy to the Operational Model of Black and 
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Leff,
52
 kAG* is largely responsible for the EC50 of the curves, while the factors A and B govern 
the Hill slope, A accounting for the observed dendrimer generation dependence. 
It is however important to note that for these well defined structures, the nanoparticle diameter, 
number of surface amino groups, and surface area all scale with generation number and are 
therefore intimately related. It has also been previously demonstrated that the (positive) zeta 
potential scales with increasing generation and therefore surface area and number of surface 
amino groups Namg
16
. In cell culture medium, the zeta potential for all generations becomes 
negative due to interaction with the medium and scales with the generation, surface area and 
therefore Namg, and notably, the magnitude of the change in the zeta potential scales with the 
dendrimer surface area. For both the SW480 and HaCaT cell line, the EC50 for a range of assays 
(Neutral Red, Alamar Blue, MTT (all 24hrs) and the clonogenic assay (8 day)) has been seen to 
scale with the surface area, the zeta potential in cell culture medium, and the change in zeta 
potential from distilled water to cell culture medium. Zeta potential depends on the dispersion 
environment, however, and is not an intrinsic nanoparticle parameter, compared to the number of 
surface amino groups, which is compositionally defined. A similar systematic correlation 
between the toxic response and the number of surface amino groups has been demonstrated for 
J774A.1 mouse macrophages.
17
 
Using only G as a nanoparticle dependent variable, resulting in a reaction rate which is dependent 
on the systematically varied physico-chemical structure of the dendrimer nanoparticles, the 
experimentally observed dose and time dependent ROS generation can be simultaneously 
simulated for all three dendrimer generations. Using this as the initiation stage of an intracellular 
response cascade, the subsequent changes in viability of the cell population at different 
timepoints, as measured using the MTT assay, can be modelled simultaneously using the 
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relatively simple rate Equation 9. As MTT primarily monitors changes in mitochondrial activity, 
changes in cell viability are related to the time dependent MMPD, as simulated by Equation 6. 
The sensitivity of the simulations to the parameter kMMP of Equation 6 is shown in 
Supplementary Information Figure S9. It is noted that, using this relatively simple formalism, an 
accurate simultaneous reproduction of the experimental results at all timepoints is not achieved. 
This is not surprising as the cascade process of cytokine activation/production and resultant 
changes to mitochondrial activity is more complex than that considered here. The first term of 
Equation 9 allows for changes in MMP without reduction of cell viability as measured by the 
MTT assay, but this did not significantly improve the simultaneous simulation of the dose 
dependent viability at different time points. 
Similarly, Equation 9 can be employed to simultaneously simulate the cytotoxicity for all three 
generations, at a fixed timepoint. In figure 5, the simulation provides an accurate reproduction of 
the experimental data, although the low dose behaviour is less well reproduced. Again, this is 
most likely a result of the relative simplicity of the model system, which doubtless does not 
include many processes which are occurring in parallel with those experimentally measured and 
considered in the model. Figure S10 of the Supplementary Information explores the sensitivity of 
the simulated viability to the parameter kMMP. No significant improvement in the discrepancy at 
low doses is achieved, although the simulated curves of Figure 5 fall largely within the 
experimental error margins. 
A potential pitfall of such modelling approaches can be 'over parameterisation' with insufficient 
experimental data that ultimately leads to 'over fitting'. In modelling the system, the minimum 
number of sequential processes have been included to describe the system, as observed 
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experimentally. Additional steps in the cascade can be added, as they are elucidated 
experimentally or by for example pathway enrichment approaches. 
It should be noted that the ROS response to PAMAM nanoparticle exposure has been observed 
to be a two stage response,
38
 and only the initial stages are modelled here. The initial response (0-
6 hrs) has been associated with encapsulation of the dendrimers in endosomes, while the later, 
secondary response has been associated with release of the nanoparticles into the cytoplasm by 
endosomolysis and subsequent incorporation into the mitochondria. A similar behaviour was 
observed by Xia et al. (2006)
12
 for ROS generation by aminated polystyrene nanoparticles. While 
the second phase of ROS generation is not modelled here, a similar rate-equation approach could 
be employed to simulate the responses, their time evolution and dependences on dose and 
dendrimer generation. A more complete understanding of generation and dose dependence of the 
process of endosomal-rupture, particle migration to and uptake by the mitochondria, and 
recovery of intracellular antioxidant levels would be required. Between the two phases, such 
phenomena as the quenching of ROS levels to below those of controls, the recovery of 
antioxidant levels, and migration of antioxidants to localised subcellular sites should be 
considered. Nevertheless, the phenomenological model is readily adaptable to include more 
complex phenomena, simply by adding additional terms to the rate-equations. However, it should 
be noted that while the ROS generation of figure 2 relates exclusively to the early stages of 
intracellular nanoparticle interactions, the later responses, in particular the later time point 
viability measurements, may be influenced by the secondary phases of ROS generation. 
Nevertheless, the model provides a valuable visualisation of the range of cellular responses to the 
exposure to nanoparticles and a faithful qualitative reproduction of the nanoparticle structural 
and dose dependences of the cytotoxic responses based on independent nanoparticle and cell 
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dependent reaction rates. Notably, experimentally observed differences between the responses of 
different cell lines can be simulated simply by adjustment of cellular passed parameters, in this 
case the rate of production of GSH, based on established differences in cell-line metabolism. In 
this context, the robustness of the model can be further validated by monitoring variations of 
ROS production and cytotoxic responses as a result of externally controlled antioxidant 
levels.
13,53,54,55,56reviewed by 57
 
Furthermore, the model also elucidates the origin in the differences of the responses of 
commonly used cytotoxicity assays and clarifies that lower observed values of EC50 for different 
assays as a measure of the same nanoparticle/cell-line system are an indication that the assays are 
registering cellular responses at later stage in the response cascade. Although the time responses 
have not explicitly been measured, the simulations of Figure 8 indicate that the variations of 
responses can be well modelled by Equations 13 and 14, which have the same form as the 
viability simulations of Equation 9, keeping all parameters of the earlier stage responses constant. 
Figure S11 shows the variability of the fits to changes in the parameters m and p. 
The use of such rate equation models for the simulation or fitting of complex systems is by no 
means novel and has become more prevalent in pharmacokinetics/pharmacodynamics.
58,59
 In 
terms of nanobio interactions, Salvati et al. employed a rate equation approach to model the 
uptake of polystyrene nanoparticles in cells as measured by the fluorescent response of the cell 
populations, although no modelling of the cellular responses was undertaken.
14
 Dell’Orco et al. 
used a similar approach, described in terms of Systems Biology, to model the delivery success 
rate of engineered nanoparticles and its dependence on the presence and structure of the protein 
corona.
60
 To our knowledge, however, this is the first use of such models to simulate the time 
evolution, dose and structural dependence of cellular responses to nanoparticle exposure and to 
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derive toxicological endpoints from the simulated data. Undoubtedly, the approach is crude at 
this stage, and improvements based on fitting of the data by for example nonlinear regression
59
 or 
parameter global sensitivity analysis (GSA)
60
 could significantly enhance the robustness of the 
model. Parameter GSA simultaneously varies all the parameters within the parameter space to 
evaluate their effect on the system.
60
 Program packages are available to aid this analysis, such as: 
SBML-SAT (Systems biology markup language - sensitivity analysis tool). This program allows 
for evaluation using a range of different methods, including Sobol’s Method, Weighted average 
of local sensitivity analysis, multi-parametric sensitivity analysis and partial rank correlation co-
efficient. The program can also handle discontinuous events, which could be beneficial for the 
system in question.
61
 While this sort of modeling shows potential for the future it is worthy to 
note that uncertainty still remains an issue. For example a study by Bennett et al, shows that 
when calculating one parameter using a range of different models, the results can be orders of 
magnitude in difference.
62
 Differences will always be present in these models as different models 
utilize different methods for prediction. However, the scale of the differences should be reduced, 
particularly by larger validation sets and more detailed applicability domains. 
Nevertheless, the model helps to visualise the complex range of responses which can occur upon 
exposure of in vitro cell cultures to nanoparticles. The experimentally observed cascade of events 
resulting from oxidative stress and subsequent inflammatory responses can readily be modelled. 
The dose dependence is complex, but can be modelled and related to the nanoparticle physico-
chemical properties. Critically, the model demonstrates the temporal responses are dynamic and 
the dose dependences are complex, and therefore that it is not sufficient to measure cellular 
responses at a fixed dose or time point. Ideally, the complete 3-D profile of time, dose and 
response should be measured for all particles, structural variations, assays and cell-lines. Such an 
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exercise would be exhaustive, in terms of time and cost, however, and numerical simulation 
models such as the one presented here can be of great benefit in reducing the effort. 
Notably, the model allows to differentiate the impact on the viability endpoint of nanoparticle 
based parameters from cellular based parameters, and for a single cell line, the entire range of 
responses to the exposure to three different dendritic nanoparticles has been reduced to the two 
parameters of rate of endocytosis and rate of ROS generation. Within a single cell line, the 
differing responses of the different cytotoxicity assays are consistent with sensitivity to different 
stages of the cellular response cascade. Extending to different cell-lines, the variation of response 
can be accounted for by differences in intracellular antioxidant levels, although cell-line 
dependent differences in rate of endocytosis and rate of ROS generation, for the same 
nanoparticles cannot be ruled out and need to be experimentally verified.  
The representation of the cellular responses in terms of a causally related sequence of events 
leading to cell death lends itself naturally to an AOP formalism, and such a formalism can be 
advantageous to regulatory bodies as it will identify the critical step in the sequence leading to a 
toxic response, in this case ROS production. Although AOPs developed to-date are primarily 
qualitative in nature, the work described in this manuscript could be described as modelling a 
'partial' AOP or Toxicity Pathway that comprises events at the molecular and cellular level. 
Additionally, the systems biology like approach adds quantification of the rates of response, 
which are related in the initial stages to the physico-chemical properties of the nanoparticles. By 
coupling these two approaches it may be possible to calculate an amount or rate of ROS 
production, from which the cell cannot recover, which would form the cut off point (acceptable 
limit) of whether the nanoparticle would be considered dangerous or not. Of course cellular 
quenching of ROS via antioxidant activity would also have to be considered. Such an approach 
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may ultimately lead to predictive models of cytotoxic response and the basis of QSARs. In terms 
of the development of QSARs, the study and modelling of homologous series of nanoparticles 
contributes greatly to interpreting the mechanism of response, but also quantifiably relating the 
endpoint (EC50) to the nanoparticle physico-chemical properties. The model further indicates, at 
least within the homologous series presented here, that the determining factor of the toxic 
response is the rate of generation of ROS, and that this may be considered a defined endpoint for 
the construction of QSARs. Obviously, the domain of applicability of such a model would need 
to be expanded by studies of a broader range of polymeric and other nanoparticles whose surface 
chemistry is well defined and ideally systematically variable. Only then can a reliable statistical 
validation of reliability and robustness of the model be considered. In constructing the model, 
simulations have been performed simultaneously for either: three dendrimer generations (Figures 
2 and 5), timepoints (Figure 4), cell lines (Figure 7) or assays (Figure 8), keeping all other 
parameters constant. This suggests that, once the model has been established, it should be readily 
extendable to, for example, further generations of PAMAM dendrimer, similar homologous 
cationic dendrimer series such as Poly(propylene imine), or other aminated polymer 
nanoparticles such as polystyrene and that the responses should be quantitatively predictable 
based on the number of surface amino groups. Work is ongoing to demonstrate that the model 
can be quantitatively translated to such systems, and thereby demonstrate a broader domain of 
applicability. Ultimately, it may be possible to characterise the surface reactivity, and thus the 
rate of generation of ROS acellularly, such that the model could the readily be extended to other 
more complex particle types that act via ROS mediated cellular stress pathways such as metal 
oxides, and the parameter may be used as input into such a model to predict the in vitro 
cytotoxicity. 
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Conclusion 
The plethora of in vitro studies of nanoparticle toxicity demand that a more structured approach 
to classification and understanding. In this context, homologous series of particles of 
systematically variable physico-chemical properties play an important role, and the 
systematically varied cellular responses facilitate the development of mathematical models based 
on the mechanisms of response.  
This study demonstrates how such an approach can be used to faithfully reproduce and visualise 
the time and dose dependant response, for three polymer dendrimer nanoparticles 
simultaneously, and to construct a 3D toxicity profile to model the structurally dependent 
nanoparticle uptake and resultant oxidative stress and inflammatory cascade, leading to apoptosis 
and cell death. The phenomenological rate equation approach lends itself naturally to tracking the 
kinetics of the response, but the dose dependent toxicological end point at a fixed time point can 
similarly be modelled.   
The model is also readily extendable to different cell lines, simply by changing a cell based 
parameter such as kGSH and while the full range of components of the inflammatory/apoptotic 
cascade have not yet been experimentally visualised, the model can replicate the results of the 
cytotoxicity assays by solving for viability at different steps in the sequence. Furthermore, the 
system of equations used is versatile and can be readily modified to include additional cascade 
steps and new parameters as the experimental data become available. 
Work is ongoing to apply the model to a range of different particles and cell lines. This current 
work serves to show that these mathematical models hold potential in predicting nanoparticle 
toxicity and will, with further development, provide a viable alternative to testing of each particle 
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via a case-by-case approach. The models also have potential uses in a regulatory capacity and by 
combining these quantative methods with qualitative methods (such as AOPs) it will be easier to 
evaluate and apply limits of acceptability to the toxic response. 
 
 
 44 
Author Contributions 
All authors have given approval to the final version of the manuscript. 
Funding Sources 
Irish Government's Programme for Research in Third Level Institutions, Cycle 4, National 
Development Plan 2007-2013, supported by the European Union Structural Fund. M Maher is 
funded through the DIT Fiosraigh President’s Award for Research Excellence 2010 
Declaration of interest 
The authors declare no conflict of interest related to the work presented in this manuscript. 
Keywords  
Nanotoxicology, Polyamidoamine Dendrimer, Reactive Oxygen Species, Inflammatory cascade, 
Cytotoxicity, Rate Equation Model, Numerical Simulation, Quantitative Structure Activity 
Relationships  
Acknowledgements  
This work was conducted in part under the framework of the INSPIRE programme, funded by 
the Irish Government's Programme for Research in Third Level Institutions, Cycle 4, National 
Development Plan 2007-2013, supported by the European Union Structural Fund. M Maher is 
funded through the DIT Fiosraigh President’s Award for Research Excellence 2010. 
Abbreviations  
ROS, reactive oxygen species. EC50, effective concentration 50%. QSAR, quantative structure 
activity relationship. PAMAM, polyamidoamine. GSH, glutathione. MMPD, mitochondrial 
 45 
membrane depolarization. TNF-α, tumour necrosis factor – alpha. IL-8, interleukin-eight, IL-6, 
interleukin 6. 
 46 
References 
1. Project on Emerging Nanotechnologies (PEN), http://www.nanotechproject.org/, 2013 
2. Jain, K.K. Applications of Nanobiotechnology in Clinical Diagnostics. Clinical Chemistry, 53, 
2002–2009 (2007) 
3. Balasundaram, G., Sato, M., Webster T.J. Using hydroxyapatite nanoparticles and decreased 
crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. Biomaterials, 
27, 2798–2805 (2006) 
4. Nishimura, I., Huang, Y., Butz, F., Ogawa, T., Lin, A. and Wang, C.J. Discrete deposition of 
hydroxyapatite nanoparticles on a titanium implant with predisposing substrate microtopography 
accelerated osseointegration. Nanotechnology, 18, 1-9 (2007) 
5. Nair, H.B., Sung, B., Yadav, V.R., Kannappan, R., Chaturvedi, M.M. and Aggarwal, B,B. 
Delivery of anti-inflammatory nutraceuticals by nanoparticles for the prevention and treatment of 
cancer. Biochemical Pharmacology, 80, 1833–1843 (2010) 
6. Bharali, D.J., Khalil, M., Gurbuz, M., Simone, T.M., Mousa, S.A. Nanoparticles and cancer 
therapy: A concise review with emphasis on dendrimers. Int. J. Nanomed., 4, 1–7 (2009) 
7. Koo, O.M., Rubinstein, I. and Onyuksel, H. Role of nanotechnology in targeted drug delivery 
and imaging: a concise review. Nanomed: Nanotech. Bio. Med., 1, 193– 212 (2005) 
8. Hans, M.L. and Lowman, A.M. Biodegradable nanoparticles for drug delivery and targeting. 
Curr. Opin. Solid St. M., 6, 319–327 (2002) 
 47 
9. Watson, P., Jones, A.T. and Stephens, D.J. Intracellular trafficking pathways and drug 
delivery: fluorescence imaging of living and fixed cells. Adv. Drug Deliver. Rev., 57, 43-61 
(2005) 
10. De Jong, W. H. and Borm, P.J.A. Drug delivery and nanoparticles: Applications and hazards. 
Int. J. Nanomed., 3, 133–149 (2008) 
11. Jain, K.K., P. Gupta, U. and Jain, N.K. Dendrimer toxicity: Let’s meet the challenge. Int. J. 
Pharm., 394, 122–142 (2010) 
12. Xia, T., Kovochich, M., Brant, J., Hotze, M., Sempf, J., Oberley, T., Sioutas, C., Yeh, J.I., 
Wiesner, M.R. and Nel, A.E. Comparison of the Abilities of Ambient and Manufactured 
Nanoparticles to Induce Cellular Toxicity According to an Oxidative Stress Paradigm. Nano 
Lett., 6, 1794-1807 (2006) 
13. Nel, A., Xia, T., Mädler, L. and Li N. Toxic potential of materials at the nanolevel. Science, 
311, 622-627 (2006) 
14. Salvati, A., Aberg, C., dos Santos, T., Varela, J., Pinto, P., Lynch, I. and Dawson K.A. 
Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and 
small molecules: toward models of uptake kinetics. Nanomed: Nanotech. Bio. Med., 7, 818-826 
(2011) 
15. Kennedy, I.M., Wilson, D. and Barakat, A.I. Uptake and Inflammatory Effects of 
Nanoparticles in a Human Vascular Endothelial Cell Line. HEI Research Report 136, Health 
Effects Institute, Boston, MA (2009) 
 48 
16. Mukherjee, S.P., Davoren, M. and Byrne H.J. In vitro mammalian cytotoxicological study of 
PAMAM dendrimers - towards quantitative structure activity relationships. Toxicol. in Vitro, 24, 
169-177 (2010 a) 
17. Naha, P.C., Davoren, M., Lyng, F.M. and Byrne, H.J. Reactive oxygen species (ROS) 
induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cells. Toxicol. 
Appl. Pharm., 246, 91–99 (2010) 
18. Rothen-Rutishauser, B., Mühlfeld, C., Blank, F., Musso, C. and Gehr, P. Translocation of 
particles and inflammatory responses after exposure to fine particles and nanoparticles in an 
epithelial airway model. Part. Fibre. Toxicol., 4. doi: 10.1186/1743-8977-4-9 (2007) 
19. Schins, R.P., McAlinden, A., MacNee, W., Jimenez, L.A., Ross, J.A., Guy, K., Faux, S.P. 
and Donaldson, K. Persistent Depletion of I Kappa B Alpha and Interleukin-8 Expression in 
Human Pulmonary Epithelial Cells Exposed to Quartz Particles. Toxicol. Appl. Pharm., 167, 
107–117 (2000) 
20. Shvedova, A.A., Castranova, V., Kisin, E.R., Schwegler-Berry, D., Murray, A.R., 
Gandelsman, V.Z., Maynard, A. and Baron, P. Exposure to carbon nanotube material: assessment 
of nanotube cytotoxicity using human keratinocyte cells. J. Tox. Env. Heal. A, 66, 1909-1926 
(2003) 
21. Medina, C., Santos-Martinez, M.J., Radomski, A., Corrigan, O.I. and Radomski, M.W. 
Nanoparticles: pharmacological and toxicological significance. Brit. J. Pharmacol., 150, 552–558 
(2007) 
 49 
22. Lee, J.H., Cha, K.E., Kim, M.S., Hong, H.W., Chung, D.J., Ryu, G. and Myung, H. 
Nanosized polyamidoamine (PAMAM) dendrimer-induced apoptosis mediated by mitochondrial 
dysfunction. Toxicol. Lett., 190, 202–207 (2009) 
23. Mukherjee, S.P., Lyng, F.M., Garcia, A., Davoren, M. and Byrne H.J. Mechanistic studies of 
in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells. Toxicol. Appl. 
Pharm., 248, 259–268 (2010 b) 
24. Naha, P.C. and Byrne, H.J. Generation of Intracellular Reactive Oxygen Species and 
Genotoxicity effect to Exposure of Nanosized Polyamidoamine (PAMAM) dendrimers in PLHC-
1 cells in vitro. Aquatic Toxicology, 132-133, 61-72 (2013) 
25. Jeng, H.A. and Swanson, J. Toxicity of Metal Oxide Nanoparticles in Mammalian Cells. J. 
Environ. Sci. Heal. A, 41, 2699-2711 (2006) 
26. Oomen, A., Bos, P., Fernandes, T., Hund-Rinke, K., Boraschi, D., Byrne, H. J., Aschberger, 
K., Gottardo, S., von der Kammer, F., Kühnel, D., Hristozov, D., Marcomini, A ., Migliore, L., 
Scott-Fordsmand, J., Wick, P. and Landsiedel, R. Concern-driven integrated toxicity testing 
strategies for nanomaterials - Report of the NanoSafety Cluster Working Group 10. Nanotox., 8, 
334-348 (2014) 
27. Clark, K.A., White, R.H. and Silbergeld, E. K. Predictive models for nanotoxicology: Current 
challenges and future opportunities. Regul. Toxicol. Pharm., 59, 361-512 (2011) 
28. European Union - Directive 2010/63/EU of the European Parliament and of the Council of 22 
September 2010 on the protection of animals used for scientific purposes. (2010) 
29. United States 106th Congress - Public Law 106-545, Dec. 19, 2000. 
 50 
30. Russell, W.M.S. and Burch, R.L. The Principles of Humane Experimental Technique. 
London: Methuen (1959) 
31. Organisation for Economic Co-Operation and Development (OECD): Guidance Document 
On Developing and Assessing Adverse Outcome Pathways, OECD, ENV/JM/MONO(2013)6, 
2013. 
32. Organisation for Economic Co-Operation and Development (OECD): Guidance Document 
on the Validation of (Quantative) Structure Activity Relationships [(Q)SAR] Models, OECD, 
ENV/JM/MONO(2007)2, 2007. 
33. Puzyn, T., Leszczynska, D. and Leszczynski, J. Toward the Development of “Nano-QSARs”: 
Advances and Challenges, Small, 22, 2494-2509 (2009) 
34. Tomalia, D.A. and Fréchet, J.M.J. Discovery of Dendrimers and Dendritic Polymers: A Brief 
Historical Perspective. J. Polym. Sci. Pol. Chem., 40, 2719–2728 (2002) 
35. Naha, P.C., Davoren, M., Casey, A. and Byrne H.J. An Ecotoxicological Study of 
Poly(amidoamine) Dendrimers-Toward Quantitative Structure Activity Relationships. Env. Sci. 
Technol., 43, 6864–6869 (2009) 
36. Kitchens, K.M., Foraker, A.B., Kolhatkar, R.B., Swaan, P.W., Ghandehari, H. Endocytosis 
and interaction of poly (Amidoamine) dendrimers with Caco-2 cells. Pharmaceut. Res., 24, 
2138–2145 (2007) 
37. Hong, S., Bielinska, A.U., Mecke, A., Keszler, B., Beals, J.L., Shi, X., Balogh, L., Orr, B.G., 
Baker, J.R.Jr and Banaszak Holl, M.M. Interaction of poly(amidoamine) dendrimers with 
 51 
supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjugate 
Chem., 15, 774–782 (2004) 
38. Mukherjee, S.P. and Byrne H.J. Polyamidoamine dendrimer nanoparticle cytotoxicity 
oxidative stress, caspase activation and inflammatory response: experimental observation and 
numerical simulation. Nanomed: Nanotech. Bio. Med., 9, 202-211 (2013) 
39. Guillot-Nieckowski, M., Eisler, S. and Diederich, F. Dendritic vectors for gene transfection. 
New J. Chem., 31, 1111-1127 (2000) 
40. Kukowska-Latallo, J.F., Bielinska, A.U., Johnson, J., Spindler, R., Tomalia, D.A. and Baker, 
J.R.Jr. Efficient transfer of genetic material into mammalian cells using Starburst 
polyamidoamine dendrimers. P. Natl. Acad. Sci. USA, 93, 4897-4902 (1996) 
41. Zhou, J., Wu, J., Hafdi, N., Behr, J.P., Erbacher, P. and Peng, L. PAMAM dendrimers for 
efficient siRNA delivery and potent gene silencing. Chem. Commun., 22, 2362–2364 (2006) 
42. Atkinson, K.A. An Introduction to Numerical Analysis (2nd ed.), New York: John Wiley & 
Sons, ISBN 978-0-471-50023-0 (1989) 
43. Einstein, A. Strahlungs-emission und -absorption nach der Quantentheorie. Verhandlungen 
der Deutschen Physikalischen Gesellschaft, 18, 318–323 (1916) 
44. Snow E.T., Sykora P., Durham T.R., Klein C.B. Arsenic, mode of action at biologically 
plausible low doses: What are the implications for low dose cancer risk? Toxicol. Appl. Pharm., 
207, S557 – S564 (2005) 
 52 
45. Nakagawa, Y., Akao, Y., Morikawa, H., Hirata, I., Katsu, K., Naoe, T., Ohishi, N. and Yagi, 
K. Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines. 
Life Sciences, 70, 2253–2269 (2002) 
46. Shen, L. and Sevanian, A. OxLDL induces macrophage γ-GCS-HS protein expression: a role 
for oxLDL-associated lipid hydroperoxide in GSH synthesis. J. Lipid Res., 42, 813-823 (2001) 
47. Nociari, M.M., Shalev, A., Benias, P. and Russo, C. A novel one-step, highly sensitive 
fluorometric assay to evaluate cell-mediated cytotoxicity. J. Immunol. Methods, 213, 157–167 
(1998) 
48. Repetto, G., del Peso, A. and Zurita, J.L. Neutral red uptake assay for the estimation of cell 
viability/cytotoxicity. Nature Protocols, 3, 1125-1131 (2008) 
49. Ankley, G.T., Bennett, R.S., Erickson, R.J., Hoff, D.J., Hornung, M.W., Johnson, R.D., 
Mount, D.R., Nichols, J.W., Russom, C.L., Schmieder, P.K., Serrrano, J.A., Tietge, J.E. and 
Villeneuve, D.L. Adverse Outcome Pathways: A conceptual framework to support ecotoxicology 
research and risk assessment. Environ. Toxicol. Chem., 29, 730–741 (2010) 
50. Meng, T., Xia, T., George, S., and Nel, A.E. A Predictive Toxicological Paradigm for the 
Safety Assessment of Nanomaterials, ACS Nano, 3, 1620 –1627 (2009) 
51. Crooks, R.M., Lemon III, B.I., Yeung, L.K. and Zhao, M. Dendrimers III: Design, 
Dimension, Function: Dendrimer-encapsulated Metals and Semiconductors: Synthesis, 
Characterisation and Applications, Topics in Current Chemistry, 212, 81-135 (2001) 
52. Black, J.W. and Leff, P. Operational models of pharmacological agonism. Proceeding of the 
Royal Society B: Biological Sciences, 220, 141-162 (1983) 
 53 
53. Issels, R.D., Nagele, A., Eckert, K-G. and Wilmanns W. Promotion of cystine uptake and its 
utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine. Biochem. 
Pharmacol., 37, 1029-1033 (1985) 
54. Tsan, M.F., Danis, E.H., Del Vecchio, P.J. and Rosano, C.L. Enhancement of intracellular 
glutathione protects endothelial cells against oxidant damage. Biochem. Bioph. Res. Co., 127, 
270-276 (1985) 
55. Tsan, M.F., White, J.E. and Rosano, C.L. Modulation of endothelial GSH concentrations: 
effect of exogenous GSH and GSH monoethyl ester. J. Appl. Physiol., 66, 1029-1034 (1989) 
56. Vlahopoulos, S., Boldogh, I., Casola, A. and Brasier, A.R. Nuclear Factor-kB-Dependent 
Induction of Interleukin-8 Gene Expression by Tumor Necrosis Factor-α: Evidence for an 
Antioxidant Sensitive Activating Pathway Distinct From Nuclear Translocation. Blood., 94, 
1878-1889 (1999) 
57. Deneke, S.M. and Fanburg, B.L. Regulation of cellular glutathione. Am. J. Physiol., 257, 
L163-L173 (1989) 
58. Miyazaki, M., Nakade, S., Iwanaga, K., Morimoto, K., and Kakemi, M. Estimation of 
bioavailability of salmon calcitonin from the hypocalcemic effect in rats (I): pharmacokinetic–
pharmacodynamic modeling based on the endogenous Ca regulatory system. Drug Metabol. 
Pharmacokinetics, 18, 350-357 (2003) 
59. Ryan, S.M., Frías, J.M., Wang, X., Sayers. C.T., Haddleton, D.M. and Brayden, D.J. PK/PD 
modelling of comb-shaped PEGylated salmon calcitonin conjugates of differing molecular 
weights. J. Controlled Release, 149, 126–132 (2011) 
 54 
60. Dell’Orco, D., Lundqvist, M., Cedervall, T. and Linse, S. Delivery success rate of engineered 
nanoparticles in the presence of the protein corona: a systems-level screening. Nanomed: 
Nanotech. Bio. Med., 8, 1271-1281 (2012) 
61. Zi, Z., Zheng, Y., Rundell, A.E. and Klipp, E. SBML-SAT: a systems biology markup 
language (SBML) based sensitivity analysis tool. BMC Bioinformatics, 9, 342 (2008) 
62. Bennett, E.R., Clausen, J., Linkov, E. and Linkov, I. Predicting physical properties of 
emerging compounds with limited physical and chemical data: QSAR model uncertainty and 
applicability to military munitions. Chemosphere, 77, 1412-1418 (2009) 
 55 
Numerical simulations of in vitro nanoparticle toxicity - Towards 
structure activity relationships and predictive models for toxicology 
and medicine.   
Marcus A. Maher
*
, Pratap C. Naha
†
, Sourav Prassana Mukerjee
§
, Hugh J. Byrne 
Focas Research Institute, Dublin Institute of Technology, Kevin Street, Dublin 8, Ireland. 
† Now at: Department of Radiology, Perelman School of Medicine, University of Pennsylvania, 
Philadelphia, Pennsylvania 19104, USA 
§ Now at: Health Canada, Mechanistic Studies Division, Ottawa, Ontario, Canada 
Supplementary Information: 
Table S1: Parameters employed for the final simulated datasets. 
dt 0.1 hr 
kA 0.0011 hr
-1
 
RT0 10M 
kendo 0.75 hr
-1
 
c 0.25 
kGSH 1.00 hr
-1
 
kq 0.40 hr
-1
 
kλ (ln2/24) hr
-1
 
B 3 
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Nsource(t=0) 10M 
kcasp 0.02 hr
-1
 
kcasp2 0.30 hr
-1
 
kmmp 0.001 hr
-1
 
ktnf 0.035 hr
-1
 
kil8 0.10 hr
-1
 
kV 8.00 hr
-1
 
krec 0.065 hr
-1
 
kROS 1.20  hr
-1
 
 
In previous work
SR1
, the time dependent rise and subsequent decay of the generation of ROS was 
modelled according to equation (10). However, such a model does not accurately account for the 
observed dose dependence, as shown in figure S1. Although an initial saturation-like behaviour 
is observable at intermediate doses, at higher doses the levels of ROS continue to increase 
monotonically. 
 
 57 
Figure S1: Dose dependent ROS generation for all generations simulated according to Equation 
10. 
The experimentally observed dose and time dependence of the increased levels of ROS is 
faithfully reproduced, however, by invoking the concept of a source of ROS which is depleted 
according to Equation 11, resulting in a dose and time dependent generation of ROS according to 
Equation 12 as shown in Figure 2.  
Figure S2 shows the simulated uptake of nanoparticles, Nendo, calculated according to Equation 2, 
for PAMAM generations G4, G5, G6, with values of c = 0.25, k = (ln2/24)hr
-1
. Similar to the 
behaviour observed by Salvati et al.
SR2
 for aminated polystyrene nanoparticles, the response 
increases approximately linear at early times, but deviates from linearity as the cells divide and 
the nanoparticles are distributed over a larger cell population. Although no values of kendo are 
quoted by Salvati et al., the experimental data in their study are best fitted by a regime in which 
kendo>k . In figure S1, kendo = 0.75 hr
-1 
> k = 0.03 hr
-1
. 
 
 58 
 
Figure S2: Simulated time dependent uptake of PAMAM dendrimers of generation G4, G5, G6, 
according to Equation 2, at a fixed dose of 1 m.   
The effect of variation in kendo is also manifest in the dose dependent evolution of the ROS levels 
for all generations, as shown in Figure S3, for the example of 4hrs exposure. Variation of kendo 
has the effect of systematically shifting the median dose point of ROS increase. The best 
reproduction of the experimentally observed behaviour for the combined dataset of three 
dendrimer generations was found with kendo=0.75 hr
-1
. 
 
ROS Source Discussion 
Confocal microscopic studies of mammalian cell exposure to PAMAM dendrimers by Mukherjee 
et al. have clearly demonstrated co-localisation of the early stage ROS with endosomes.
SR3,SR4
 In 
the case of cationic nanoparticles in the acidifying environment of endosomes, it is reported that 
the unsaturated surface amino groups sequester protons that are supplied by the v-ATPase 
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(proton pump).
SR5
 This process keeps the pump functioning and leads to the retention of one Cl
–
 
ion and one water molecule per proton. It has been proposed that the initial wave of ROS may be 
produced via NADPH oxidase.
SR6
 NADPH oxidase is an enzyme which produces superoxide 
anions (O2
-
) in phagosomes and endosomes.
SR7
 Evidence also points to the release of the 
superoxide to the cytoplasm via chloride anion channels.
SR7
 Superoxide production is 
accomplished by an electron transfer from NADPH, via FAD, to molecular oxygen (O2). The O2
-
 
then rapidly dismutases to hydrogen peroxide (H2O2).
SR8
 It is also believed that the protons from 
the proton pump mechanism are used in the dismutation of superoxide. NADPH oxidase is 
present in nearly all cell types (including HaCaT cells
SR9
) and is important in both host defences 
and redox signalling.
 Reviewed by SR10 and SR11
 NADPH oxidase has been implicated in the production 
of ROS in nanoparticle induced toxicity for other nanoparticles, including silica, etc.
SR12,SR13
 The 
idea that NADPH oxidase is responsible for PAMAM induced toxicity deserves further attention 
and may aid in a deeper understanding of the underlying processes involved in nano-cytotoxicity.
 60 
A: 
 
Figure S3-A: kendo = 0.25hr
-1
 
B: 
 
Figure S3-B: kendo = 0.75hr
-1
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C: 
 
Figure S3-C: kendo = 1.25hr
-1
 
Figure S3: Variation in simulated (lines) increase in ROS levels on the parameter kendo in 
Equation 2, compared to experimental data (symbols) for G4, G5, G6. A: kendo = 0.25hr
-1
, B: 
kendo = 0.75 hr
-1
, C: kendo = 1.25hr
-1
. 
 
The generation dependence of the uptake (also demonstrated in Mukherjee, S.P. and Byrne H.J. 
2013
SR1
) derives from the term (Namg)
c
 in Equation 2, and although the uptake of the dendrimers 
cannot be directly visualised, the effect of this term on the generation dependent increase in ROS 
levels is demonstrated in figure S4. The generation dependent factor similarly has the effect of 
shifting the dose dependent curves along the dose axis, but also systematically varies the 
separation of the responses for the different dendrimer generations. The best reproduction of the 
ROS curves was obtained using a value of c=0.25, as shown in figure S4:B. 
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A: 
 
Figure S4-A: c = 0 
B: 
 
Figure S4-B: c = 0.25 
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C: 
 
Figure S4-C: c = 1 
Figure S4: Variation in simulated (lines) increase in ROS levels on the parameter (Namg)
c
 in 
Equation 2, compared to experimental data (symbols) for G4, G5, G6. A: c = 0, B: c = 0.25 and 
C: c = 1. 
 
Figure S5 illustrates the sensitivity of the simulations to variations in the parameter kA in 
Equations 11 and 12. The parameter largely impacts on the separation of the dose dependences of 
the different generations. The best reproduction of the experimental behaviour was observed with 
a value of kA = 0.0011 hr
-1
. 
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A: 
 
Figure S5-A: kA = 0.0004 hr
-1
 
B: 
 
Figure S5-B: kA = 0.0011 hr
-1
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C: 
 
Figure S5-C: kA = 0.0018 hr
-1
 
 
Figure S5: Variation in simulated (lines) increase in ROS levels on the parameter kA compared to 
experimental data (symbols) for G4, G5, G6. A: kA = 0.0004 hr
-1
, B: kA =0.0011hr
-1 
and C: kA = 
0.0018 hr
-1
. 
 
Figure S6 shows how the dose dependant ROS values vary with the G* parameter. Since G* = 
1/(Namg
0.25
) the variance was observed by changing the exponent value (0.25). 
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A: 
 
Figure S6-A: Exponent value = 0.083 
B: 
 
Figure S6-B: Exponent value = 0.25 
C: 
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Figure S6-C: Exponent value = 0.42 
Figure S6(A-C): Variation in simulated (lines) increase in ROS levels on the exponential value in 
the equation G*=1/(Namg
0.25
), compared to experimental data (symbols) for G4, G5, G6. A: 
Exponent value = 0.083, B: Exponent Value = 0.25, C: Exponent Value = 0.42. 
Figure S7 shows how the dose dependant ROS values vary with the parameter A. Since A = 
(Namg/64)
0.75
 the variance was observed by changing the exponent value (0.75). 
A: 
 
Figure S7-A: Exponent value = 0.25 
B: 
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Figure S7-B: Exponent value = 0.75 
C: 
 
Figure S7-C: Exponent value = 1.25 
Figure S7(A-C): Variation in simulated (lines) increase in ROS levels on the exponential value in 
the equation A=(Namg/64)
0.75
, compared to experimental data (symbols) for G4, G5, G6. A: 
Exponent value = 0.25, B: Exponent Value = 0.75, C: Exponent Value = 1.25. 
Figure S8(A-C) shows how the does dependant ROS production varies with the parameter B of 
Equations 11 and 12. It can be seen that this parameter has a dramatic effect on the overall shape, 
dose and generation dependence of the curves. A best reproduction of the experimental 
behaviour was obtained with B=3. 
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A: 
 
Figure S8-A: B = 1 
 
 
 
 
 
 
B: 
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Figure S8-B: B = 3 
C: 
 
Figure S8-C: B = 5 
 
Figure S8: Variation in simulated (lines) increase in ROS levels on the parameter B in Equation 
11/12, compared to experimental data (symbols) for G4, G5, G6. A: B = 1, B: B = 3 and C: B = 
5. 
Figure S9 shows how the viability of the cells (for G4 at three timepoints), as calculated using 
Equation (9) is affected by the parameter kMMP. 
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A: 
 
Figure S9-A: kMMP = 0.0007 
B: 
 
Figure S9-B: kMMP = 0.0010 
C: 
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Figure S9-C: kMMP = 0.0013 
 
Figure S9(A-C): Effect of variation of the parameter kMMP on simulated (lines) viability 
compared to experimental data (symbols) for G4 at timepoints: 6hrs, 12hrs and 24hrs. A: kMMP = 
0.0007, B: kMMP = 0.0010 and C: kMMP = 0.0013. 
 
Figure S10 shows how the viability of the cells (for 3 generations of nanoparticle), as calculated 
using Equation (9) is affected by the parameter kMMP. 
A: 
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Figure S10-A: kMMP = 0.0007 
B: 
 
Figure S10-B: kMMP = 0.0010 
C: 
 
Figure S10-C: kMMP = 0.0013 
 
Figure S10(A-C): Effect of variation of the parameter kMMP on simulated (lines) viability 
compared to experimental data (symbols) for G4, G5, G6. A: kMMP = 0.0007, B: kMMP = 0.0010 
and C: kMMP = 0.0013. 
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Figure S11 shows how the viability of the cells, as calculated using Equation (9) is affected by 
the exponent value “m” in equation 13. 
A: 
 
Figure 11-A: m=1 
B: 
 
Figure 11-B: m=2 
C: 
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Figure 11-C: m=3 
Figure S11(A-C): Effect of variation of the parameter m (dotted line) on simulated (lines) 
viability compared to experimental data (symbols) for 3 different assay types . A: m = 1, B: m = 
2 and C: m = 3. 
Figure S12 shows how the viability of the cells, as calculated using Equation (9) is affected by 
the exponent value “p” in equation 14. 
 
A: 
 
Figure 12-A: p=2 
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B: 
 
Figure 12-B: p=3 
 
 
 
 
 
C: 
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Figure 12-C: p=4 
Figure S12(A-C): Effect of variation of the parameter p (dashed line) on simulated (lines) 
viability compared to experimental data (symbols) for 3 different assay types . A: p=2, B: p=3 
and C: p=4. 
 78 
References 
SR1. Mukherjee, S.P. and Byrne H.J. Polyamidoamine dendrimer nanoparticle cytotoxicity 
oxidative stress, caspase activation and inflammatory response: experimental observation and 
numerical simulation. Nanomed: Nanotech. Bio. Med., 9, 202-211 (2013) 
SR2. Salvati, A., et al. Experimental and theoretical comparison of intracellular import of 
polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomed: 
Nanotech. Bio. Med., 7, 818-826 (2011) 
SR3. Mukherjee, S.P., Davoren, M. and Byrne H.J. In vitro mammalian cytotoxicological study 
of PAMAM dendrimers - towards quantitative structure activity relationships. Toxicol. in Vitro, 
24, 169-177 (2010 a) 
SR4. Mukherjee, S.P., Lyng, F.M., Garcia, A., Davoren, M. and Byrne H.J. Mechanistic studies 
of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells. Toxicol. Appl. 
Pharm., 248, 259–268 (2010 b) 
SR5. Nel, A.E., Mädler, L., Velegol, D., Xia, T., Hoek, E.M.V., Somasundaran, P., Klaessig, F., 
Castranova, V. and Thompson, M. Understanding biophysicochemical interactions at the nano–
bio interface. Nature Materials, 8, 543 - 557 (2009) 
SR6. Xia, T., Kovochich, M., Brant, J., Hotze, M., Sempf, J., Oberley, T., Sioutas, C., Yeh, J.I., 
Wiesner, M.R. and Nel, A.E. Comparison of the Abilities of Ambient and Manufactured 
Nanoparticles to Induce Cellular Toxicity According to an Oxidative Stress Paradigm. Nano 
Lett., 6, 1794-1807 (2006) 
 79 
SR7. Shuvaev, V.V., Han, J., Yu, K.J., Huang, S., Hawkins, B.J., Madesh, M., Nakada, M. and 
Muzykantov, V.R. PECAM-targeted delivery of SOD inhibits endothelial inflammatory 
response. FASEB, 25, 348-357 (2011) 
SR8. Babior, B.M., Lambeth, J.D. and Nauseef, W. The neutrophil NADPH oxidase. Arch. 
Biochem Biophys., 397, 342–344 (2002) 
SR9. Chamulitrat, W., Stremmel, W., Kawahara, T., Rokutan, K., Fujii, H., Wingler, K., 
Schmidt, H.H. and Schmidt, R. A constitutive NADPH oxidase-like system containing gp91phox 
homologs in human keratinocytes. J. Invest. Dermatol., 122, 1000-1009 (2004) 
SR10. Bedard, K. and Krause, K.H. The NOX Family of ROS-Generating NADPH Oxidases: 
Physiology and Pathophysiology. Physiol. Rev., 87, 245–313 (2007) 
SR11. Masuko, U.F. Localizing NADPH Oxidase–Derived ROS. Science Signalling: The Signal 
Transduction Knowledge Environment, 2006(349), re8 (2006) 
SR12. Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B.T. and Tschopp, J. 
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica. 
Science, 320, 674-677 (2008) 
SR13. Nabeshi, H., Yoshikawa, T., Matsuyama, K., Nakazato, Y., Tochigi, S., Kondoh, S., Hirai, 
T., Akase, T., Nagano, K., Abe, Y., Yoshioka, Y., Kamada, H., Itoh, N., Tsunoda, S. and 
Tsutsumi, Y. Amorphous nanosilica induce endocytosis-dependent ROS generation and DNA 
damage in human keratinocytes. Particle and Fibre Toxicology, 8(1), 10 pages (2011) 
 
